A hypothetical intervention on the use of hearing aids for the risk of dementia in people with hearing loss in UK Biobank - Report - MDSpire

A hypothetical intervention on the use of hearing aids for the risk of dementia in people with hearing loss in UK Biobank

  • By

  • Jure Mur

  • Matthias Klee

  • Helen R Wright

  • Alina Solomon

  • Christine Johnson

  • Thomas J Littlejohns

  • Graciela Muniz-Terrera

  • Anja K Leist

  • December 16, 2024

  • 0 min

Share

Impact of Hearing Aid Use on Dementia Risk in UK Biobank Hearing-Impaired Individuals

Overview

This study used UK Biobank data to examine the effect of hearing aid (HA) use on dementia risk among individuals with incident hearing loss (HL). Contrary to expectations, HA users showed a higher risk of dementia diagnosis than nonusers, but this association was substantially attenuated after adjusting for healthcare utilization, suggesting residual confounding.

Background

Hearing loss is a common, modifiable risk factor for dementia, with a population attributable fraction estimated at 7% or more in high-income countries. The causal pathway linking hearing loss and dementia remains unclear, with hypotheses including shared pathology or increased cognitive load due to impaired hearing. Hearing aids improve hearing and might be expected to reduce dementia risk if hearing loss causally contributes to cognitive decline. However, randomized controlled trials have been limited by short follow-up and have not demonstrated clear benefits of hearing aids on dementia risk. Observational data analyzed with causal inference methods can complement these trials.

Data Highlights

MeasureRisk Ratio (95% CI)
HA users vs nonusers (unadjusted)1.43 (1.08-1.88)
HA users vs nonusers (sensitivity analyses)1.34-1.59
Adjusted for primary healthcare use0.77 (0.44-1.33)
Adjusted for primary and secondary healthcare use0.68 (0.39-1.18)
Adjustment effect smaller when early HL diagnoses includedRisk ratio ~1.30 (0.94-1.78)

Key Findings

  • HA users had a higher observed risk of dementia diagnosis compared to nonusers (risk ratio 1.43).
  • Associations remained robust across multiple sensitivity analyses (risk ratios 1.34-1.59).
  • Adjustment for primary and secondary healthcare utilization substantially reduced the association, suggesting confounding.
  • Including participants with earlier hearing loss diagnoses lessened the reduction in effect estimates after adjustment.
  • Findings indicate residual confounding by healthcare use and timing of hearing loss diagnosis in UK Biobank data.

Clinical Implications

Clinicians should interpret observational associations between hearing aid use and dementia risk cautiously, considering potential confounding by healthcare engagement. While hearing aids remain important for managing hearing loss, current evidence does not conclusively support their protective effect against dementia. Further research with rigorous causal designs and longer follow-up is needed to clarify the impact of hearing aid use on cognitive outcomes.

Conclusion

This study suggests that the observed increased dementia risk among hearing aid users is likely influenced by residual confounding related to healthcare utilization and diagnosis timing. The protective effect of hearing aids on dementia remains unproven, highlighting the need for further investigation.

References

  1. UK Biobank Study -- A Proposed Intervention Examining the Impact of Hearing Aid Usage on Dementia Risk

Original Source(s)

Related Content